Nanotechnology is increasing importance in diabetics’ research in the recent decade. It is a field that involves nanomaterials, nanostructures, nanoparticle design and their applications in humans, etc. It also provides more accurate information for diagnosing diabetes mellitus. Nanotechnology has enhanced drug delivery to those areas which were unfavorable for macromolecules. It is offering new implantable sensing technologies thus providing accurate medical information. The combination of nanotechnology and medicine has created a new field “nanomedicine” to enhance human health care. Some of the applications of nanotechnology in treating diabetes mellitus are the artificial pancreas, instead of pancreas transplantation use of artificial beta cells, oral delivery of insulin use of nanospheres as biodegradable polymeric carriers, etc. In this study, applications of nanotechnology in treating diabetes mellitus are discussed.
Nanotechnology-based approaches hold substantial potential for improving the care of patients with diabetes. Nanoparticles are being developed as imaging contrast agents to assist in the early diagnosis of type 1 diabetes. Glucose nanosensors are being incorporated in implantable devices that enable more accurate and patient-friendly real-time tracking of blood glucose levels, and are also providing the basis for glucose-responsive nanoparticles that better mimic the body’s physiological needs for insulin. Finally, nanotechnology is being used in non-invasive approaches to insulin delivery and to engineer more effective vaccine, cell, and gene therapies for type 1 diabetes. Here, we analyze the current state of these approaches and discuss key issues for their translation to clinical practice
London, UK - Jun 28, 2022
London, UK - Jun 28, 2022
London, UK - Jun 29, 2022
Abstracts enquiry
Finance enquiry
Contact Enquiry
Sponsors / Advertising
Meetings International Pte Ltd, 28 Maxwell Road, 03-05 Red Dot Traffic, Singapore, 069120.
